The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

"$590m to Moderna from HHS for mRNA ‘flu vax development" was originally created and published by Pharmaceutical Technology, ...

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

As bird flu swept through Europe in 2023, the U.S. enacted import bans. In October 2023, France became the first major ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

The U.S. government invests in cutting-edge mRNA technology to enhance pandemic preparedness and combat emerging infectious threats.

The U.S. government has awarded Boston-based pharmaceutical company Moderna (MRNA) $590 million U.S. in new money to speed-up ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...